How did an ex-Silicon valley techie turn $3,000 into $80 million through options in an Australian company?

Here are five pharma & biotech companies that have risen on positive news during the past month.

With regards to Labor’s tax record: Not happy, Dan. Not happy. But Paul Keating said it all with one of his classic one-liners.

Australian home prices are likely to rise another 15% over the next 18 months being boosted by record low mortgage rates, economic recovery and FOMO.

Here’s my take on backflips, inflation, the share market and music favourites.

Investors are unknowingly heading towards a capital gains tax minefield.

A leading business figure is worried about the debt from the last two budgets following the Coronavirus. How worried should we really be?

Fortescue and CSL have been strong buys for investors this week, while Afterpay, BHP and Rio have been sold off.

US inflation rising a huge 4.2% in April has spooked tech stock players on global share markets, but should you dump these stocks or see it as a buying opportunity?

Australians young and old, working and retired will all be affected by a raft of changes announced in this week's Federal Budget.

The know-how behind detecting diseases hasn’t changed much in decades, but a new breed of ASX players are now emerging to shake up the sector.

I hate giving Treasurers/politicians a reason to think I’ve gone soft but this is the right Budget for the time.